New recurrent UTI guideline: What urologists need to know
Oct 7, 2019 · Recurrent urinary tract infections (rUTIs), defined as two culture-proven UTIs in a 6-month period or three culture-proven events in 1 year, make up a large percentage of UTIs seen in urologic practices. Although the American Urological Association has developed a guideline previously, the current climate of antibiotic overuse and resultant ...
Urology Times | News & Insights for Urologists & Health …
Latest News. Overall, 4 of 5 patients with low-grade disease who received bel-sar with light activation achieved a complete clinical response. The investigators found that only 2 (1.4%) urology programs and 12 (5.3%) OB/GYN programs included female sexual dysfunction content. “In the absence of infection, [drain and retain] is a safe strategy ...
Shock wave therapy: ED cure or unproven treatment? - Urology …
Aug 6, 2019 · Low-intensity extracorporeal shock wave therapy is a safe treatment for men with erectile dysfunction and might work to improve, or even cure, ED in some patients. But there remain important unanswered questions, including which patients are ideal candidates and which protocol and devices are best. Without answers, offering the ED treatment ...
PSMA-PET Results Reporting and Interpretation - Urology Times
Nov 28, 2022 · PSMA-PET Results Reporting and Interpretation. EP: 9. PSMA-PET: Documentation of Patient Eligibility and Reimbursement. EP: 10. The Potential of Using Artificial Intelligence in PSMA-PET Results Interpretation. EP: 11. A Summary of Recent Advances and Remaining Unmet Needs in Targeted Prostate Cancer Imaging. EP: 12.
Peyronie’s device improves length, curvature - Urology Times
Aug 15, 2019 · Investigators looked at the device (RestoreX) in a recent study, and preliminary findings suggest using it for 30 to 90 minutes daily may result in statistically significant improvements in penile length and curvature after 3 months with no significant adverse events. “We were a bit surprised by the findings.
Long-term results of Rezum therapy for patients with large prostates
Dec 23, 2021 · So, the retreatment rate for our small prostate cohort was 4.4%, which is in line with the results demonstrated from the original WATER clinical trial, 3 which also had a retreatment rate of 4.4%. For our large prostate cohort, this subset of patients had a retreatment rate of 18.4%, so a little less than one in five patients required ...
Transgender surgery: Videos demonstrate cutting-edge techniques
Apr 6, 2017 · Miroslav L. Djordjevic, MD, PhD, is professor of urology and surgery at the School of Medicine, University of Belgrade, Serbia. In this video, we demonstrate our technique and special considerations for orchiectomy in transgender patients. Principles include use of a vertical midline scrotal incision and maximal preservation of underlying ...
Expert discusses use prostate MRI with and without contrast
Mar 1, 2024 · In this video, Leonardo Kayat Bittencourt, MD, PhD, discusses mpMRI of the prostate. Bittencourt is vice chair of innovation in the department of radiology at UH Cleveland Medical Center, a radiologist in abdominal imaging at UH Cleveland Medical Center, associate professor of radiology at Case Western Reserve University, School of Medicine, and a …
Advancements in Minimally Invasive Surgical Options for the …
Mar 31, 2022 · Benign prostatic hyperplasia (BPH) is a noncancerous enlargement of the prostate affecting more than 40 million men in the United States with an associated prevalence that increases from 40% to 80% among men 50 to 70 years of age, respectively. 1,2 Progression of BPH leads to the subsequent development of lower urinary tract symptoms (LUTS), which …
Multiparametric-MRI in prostate cancer: An expert’s view
Aug 23, 2021 · The use of multiparametric-magnetic resonance imaging (MRI) to help guide prostate biopsies has been growing among urologists and was the subject of an American Urological Association (AUA) and the Society of Abdominal Radiology Prostate Disease Focused Panel standard operating procedure document.1 In this interview, Marc A. Bjurlin, DO, MSc, …